Trial Profile
A trial of salvage chemotherapy in metastatic colorectal cancer with combination of capecitabine and mitomycin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Mitomycin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2015 New trial record